Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding.

Overstreet DH, Kampov-Polevoy AB, Rezvani AH, Braun C, Bartus RT, Crews FT.

Alcohol Clin Exp Res. 1999 Nov;23(11):1761-71.

PMID:
10591592
2.

Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.

Hyytiä P, Ingman K, Soini SL, Laitinen JT, Korpi ER.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):391-401.

PMID:
10551276
3.
4.
5.
6.

Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.

Cowen MS, Rezvani AH, Jarrott B, Lawrence AJ.

Alcohol Clin Exp Res. 1999 Jun;23(6):1008-14.

PMID:
10397284
7.

Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.

Perfumi M, Santoni M, Cippitelli A, Ciccocioppo R, Froldi R, Massi M.

Alcohol Clin Exp Res. 2003 Oct;27(10):1554-62.

PMID:
14574225
8.

Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.

Shen J, Benedict Gomes A, Gallagher A, Stafford K, Yoburn BC.

Synapse. 2000 Dec 1;38(3):322-7.

PMID:
11020235
11.

Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.

Chan KW, Duttory A, Yoburn BC.

Eur J Pharmacol. 1997 Jan 29;319(2-3):225-8.

PMID:
9042594
12.

Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.

Rezvani AH, Overstreet DH, Levin ED, Rosenthal DI, Kordik CP, Reitz AB, Vaidya AH.

Alcohol Clin Exp Res. 2007 Jan;31(1):57-63.

PMID:
17207102
13.

Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats.

Fadda P, Tronci S, Colombo G, Fratta W.

Alcohol Clin Exp Res. 1999 Aug;23(8):1296-305.

PMID:
10470971
14.

Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.

Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.

Neuroscience. 2005;135(1):213-25.

PMID:
16111831
15.

Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.

Narita M, Khotib J, Mizoguchi H, Suzuki M, Ozaki S, Yajima Y, Tseng LF, Suzuki T.

Eur J Neurosci. 2003 Nov;18(9):2498-504.

PMID:
14622150
16.

Naloxone retards the expression of a genetic predisposition toward alcohol drinking.

Badia-Elder NE, Mosemiller AK, Elder RL, Froehlich JC.

Psychopharmacology (Berl). 1999 Jun;144(3):205-12.

PMID:
10435386
18.

Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.

Abrahao KP, Quadros IM, Souza-Formigoni ML.

Neuroscience. 2008 Oct 28;156(4):857-64. doi: 10.1016/j.neuroscience.2008.08.012. Epub 2008 Aug 19.

PMID:
18804151
20.

Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.

Kakinohana M, Nakamura S, Fuchigami T, Davison KJ, Marsala M, Sugahara K.

Br J Anaesth. 2006 Jan;96(1):88-94. Epub 2005 Nov 29.

PMID:
16317029

Supplemental Content

Support Center